Biolin has purchased life sciences companies KSV Instruments in Finland and Integration Diagnostics (IDL) in Sweden. The value of the KSV Instruments deal is EUR 1.5m and an additional payment based on the company's results going forward. Biolin already owns 47% of IDL and will purchase the remaining shares for around SEK 25m.
Vehicle is expected to hold a final close in March 2020, Unquote understands
Merger of German and Dutch peers will result in a client base of 3,500 companies
Fund's predecessor, BlackFin Financial Services Fund II, closed on €400m in 2016
GP will support the Munich-based software company's growth by broadening its product offering